Intravenous infusion of human umbilical cord Wharton ’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia

The novel coronavirus disease 2019 (COVID-19) has grown to be a global public health emergency since patients were first detected in Wuhan, China. Thus far, no specific drugs or vaccines are available to cure ...

Source: Stem Cell Research and Therapy - May 27, 2020 Category: Stem Cells Authors: Yingxin Zhang, Jie Ding, Shaoda Ren, Weihua Wang, Yapei Yang, Shuangjing Li, Min Meng, Tiejun Wu, Daliang Liu, Suochen Tian, Hui Tian, Shuangfeng Chen and Changhui Zhou Tags: Short report Source Type: research